Cargando…
1448. Impact of Mental Illness on Outcomes of Outpatients with Community-Acquired Pneumonia
BACKGROUND: According to the National Alliance on Mental Illness, one in five American adults experiences a mental health condition every year. CAP is often treated with antibiotics that can prolong the QTc interval. The primary outcome was to assess whether those with a psychiatric disorder were mo...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253015/ http://dx.doi.org/10.1093/ofid/ofy210.1279 |
_version_ | 1783373398779363328 |
---|---|
author | Mergenhagen, Kari Skelly, Megan Wattengel, Bethany Napierala, Randal Sellick, John Schroeck, Jennifer |
author_facet | Mergenhagen, Kari Skelly, Megan Wattengel, Bethany Napierala, Randal Sellick, John Schroeck, Jennifer |
author_sort | Mergenhagen, Kari |
collection | PubMed |
description | BACKGROUND: According to the National Alliance on Mental Illness, one in five American adults experiences a mental health condition every year. CAP is often treated with antibiotics that can prolong the QTc interval. The primary outcome was to assess whether those with a psychiatric disorder were more likely to experience treatment failure and have poor outcomes in the treatment of community acquired pneumonia (CAP). METHODS: A retrospective chart review was performed using ICD-9/10 codes for CAP between January 1, 2008 and January 31, 2018. Patients were included if they were seen at the Western New York VA Healthcare System, emergency room, primary or rural care clinics. Data were analyzed via the Student’s t-test or chi-squared test. RESULTS: A total of 518 patients met criteria and 49% had a psychiatric disorder. Compared with patients without psychiatric disorders, patients with psychiatric co-morbidity were more likely to receive an appropriate dose of antibiotics (99.4% vs. 93.6% P = 0.0004) as well as an appropriate duration (78% vs. 68% P = 0.03). Patients with a psychiatric disorder were not more likely to experience failure or subsequent admission. There was no statically significant difference in early or late CAP treatment failure in those with a psychiatric disorder compared with those without (P = 0.3383; P = 0.116). There was also no statistically significant difference in 30-day readmission rates, 30-day mortality, or 90-day mortality (P = 0.4095; P = 0.3383; P = 0.3790). They were more likely to be prescribed conditional risk QTc prolonging agents concomitantly (70.2% vs. 26.9% P < 0.0001); however, differences in prescribing rates of a QTc prolonging antibiotic, such as a fluoroquinolone or macrolide, were not statistically significant (85.3% vs. 83.4% P = 0.5353). CONCLUSION: While mental illness is often associated with poor outcomes, this study emphasizes the need to continue to remove the stigma of mental illness when treating patients with common outpatient infections. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6253015 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62530152018-11-28 1448. Impact of Mental Illness on Outcomes of Outpatients with Community-Acquired Pneumonia Mergenhagen, Kari Skelly, Megan Wattengel, Bethany Napierala, Randal Sellick, John Schroeck, Jennifer Open Forum Infect Dis Abstracts BACKGROUND: According to the National Alliance on Mental Illness, one in five American adults experiences a mental health condition every year. CAP is often treated with antibiotics that can prolong the QTc interval. The primary outcome was to assess whether those with a psychiatric disorder were more likely to experience treatment failure and have poor outcomes in the treatment of community acquired pneumonia (CAP). METHODS: A retrospective chart review was performed using ICD-9/10 codes for CAP between January 1, 2008 and January 31, 2018. Patients were included if they were seen at the Western New York VA Healthcare System, emergency room, primary or rural care clinics. Data were analyzed via the Student’s t-test or chi-squared test. RESULTS: A total of 518 patients met criteria and 49% had a psychiatric disorder. Compared with patients without psychiatric disorders, patients with psychiatric co-morbidity were more likely to receive an appropriate dose of antibiotics (99.4% vs. 93.6% P = 0.0004) as well as an appropriate duration (78% vs. 68% P = 0.03). Patients with a psychiatric disorder were not more likely to experience failure or subsequent admission. There was no statically significant difference in early or late CAP treatment failure in those with a psychiatric disorder compared with those without (P = 0.3383; P = 0.116). There was also no statistically significant difference in 30-day readmission rates, 30-day mortality, or 90-day mortality (P = 0.4095; P = 0.3383; P = 0.3790). They were more likely to be prescribed conditional risk QTc prolonging agents concomitantly (70.2% vs. 26.9% P < 0.0001); however, differences in prescribing rates of a QTc prolonging antibiotic, such as a fluoroquinolone or macrolide, were not statistically significant (85.3% vs. 83.4% P = 0.5353). CONCLUSION: While mental illness is often associated with poor outcomes, this study emphasizes the need to continue to remove the stigma of mental illness when treating patients with common outpatient infections. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6253015/ http://dx.doi.org/10.1093/ofid/ofy210.1279 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Mergenhagen, Kari Skelly, Megan Wattengel, Bethany Napierala, Randal Sellick, John Schroeck, Jennifer 1448. Impact of Mental Illness on Outcomes of Outpatients with Community-Acquired Pneumonia |
title | 1448. Impact of Mental Illness on Outcomes of Outpatients with Community-Acquired Pneumonia |
title_full | 1448. Impact of Mental Illness on Outcomes of Outpatients with Community-Acquired Pneumonia |
title_fullStr | 1448. Impact of Mental Illness on Outcomes of Outpatients with Community-Acquired Pneumonia |
title_full_unstemmed | 1448. Impact of Mental Illness on Outcomes of Outpatients with Community-Acquired Pneumonia |
title_short | 1448. Impact of Mental Illness on Outcomes of Outpatients with Community-Acquired Pneumonia |
title_sort | 1448. impact of mental illness on outcomes of outpatients with community-acquired pneumonia |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253015/ http://dx.doi.org/10.1093/ofid/ofy210.1279 |
work_keys_str_mv | AT mergenhagenkari 1448impactofmentalillnessonoutcomesofoutpatientswithcommunityacquiredpneumonia AT skellymegan 1448impactofmentalillnessonoutcomesofoutpatientswithcommunityacquiredpneumonia AT wattengelbethany 1448impactofmentalillnessonoutcomesofoutpatientswithcommunityacquiredpneumonia AT napieralarandal 1448impactofmentalillnessonoutcomesofoutpatientswithcommunityacquiredpneumonia AT sellickjohn 1448impactofmentalillnessonoutcomesofoutpatientswithcommunityacquiredpneumonia AT schroeckjennifer 1448impactofmentalillnessonoutcomesofoutpatientswithcommunityacquiredpneumonia |